Thioridazinhydrochlorid en es it fr

Thioridazinhydrochlorid Brand names, Thioridazinhydrochlorid Analogs

Thioridazinhydrochlorid Brand Names Mixture

  • No information avaliable

Thioridazinhydrochlorid Chemical_Formula


Thioridazinhydrochlorid RX_link

Thioridazinhydrochlorid fda sheet

Thioridazinhydrochlorid msds (material safety sheet)

Thioridazinhydrochlorid MSDS

Thioridazinhydrochlorid Synthesis Reference

Bourquin et al., Helv. Chim. Acta 41, 1072 (1958)

Thioridazinhydrochlorid Molecular Weight

370.577 g/mol

Thioridazinhydrochlorid Melting Point

73 oC

Thioridazinhydrochlorid H2O Solubility

0.0336 mg/L

Thioridazinhydrochlorid State


Thioridazinhydrochlorid LogP


Thioridazinhydrochlorid Dosage Forms

Suspension; Tablet

Thioridazinhydrochlorid Indication

For the treatment of schizophrenia and generalized anxiety disorder.

Thioridazinhydrochlorid Pharmacology

Thioridazine is a trifluoro-methyl phenothiazine derivative intended for the management of schizophrenia and other psychotic disorders. Thioridazine has not been shown effective in the management of behaviorial complications in patients with mental retardation.

Thioridazinhydrochlorid Absorption


Thioridazinhydrochlorid side effects and Toxicity

LD50=956-1034 mg/kg (Orally in rats); Agitation, blurred vision, coma, confusion, constipation, difficulty breathing, dilated or constricted pupils, diminished flow of urine, dry mouth, dry skin, excessively high or low body temperature, extremely low blood pressure, fluid in the lungs, heart abnormalities, inability to urinate, intestinal blockage, nasal congestion, restlessness, sedation, seizures, shock

Thioridazinhydrochlorid Patient Information

Thioridazinhydrochlorid Organisms Affected

Humans and other mammals